Management of Random Blood Glucose 191 mg/dL in Hospitalized Patient
For a hospitalized patient with a random blood glucose of 191 mg/dL, initiate correctional (sliding scale) insulin immediately to maintain glucose targets of 100-180 mg/dL, and if two or more readings exceed 180 mg/dL within 24 hours, add scheduled basal insulin. 1
Initial Assessment and Treatment Approach
A random blood glucose of 191 mg/dL exceeds the diagnostic threshold for inpatient hyperglycemia (>140 mg/dL) and requires treatment 2, 1. The management strategy depends on the patient's diabetes history and clinical status:
For Patients WITHOUT Known Diabetes:
- Start with correctional insulin alone as first-line therapy 1
- Target glucose range: 100-180 mg/dL
- Monitor point-of-care blood glucose regularly (typically before meals and bedtime)
- Escalate to scheduled insulin if ≥2 readings are ≥180 mg/dL in a 24-hour period 1
For Patients WITH Known Diabetes (Non-Insulin Treated):
- Either correctional insulin alone OR scheduled insulin therapy is appropriate 1
- If admission glucose is ≥180 mg/dL (confirmed), scheduled insulin therapy can be initiated immediately 1
- For persistent hyperglycemia on correctional insulin alone, add scheduled basal insulin 1
For Patients WITH Known Diabetes (Insulin-Treated):
- Continue scheduled insulin regimen modified for nutritional status and illness severity 1
- May need to reduce basal insulin by 10-20% if patient was on basal-heavy regimens (≥0.6-1.0 units/kg/day) 1
- Maintain target range of 100-180 mg/dL 1
Critical Care vs. Non-Critical Care Distinction
Since the question specifies a "hospitalized patient" without mentioning ICU status, assume non-critical care setting:
- Target range: 100-180 mg/dL (pre-meal <140 mg/dL, random <180 mg/dL) 2, 1
- Random glucose of 180 mg/dL is the threshold for treatment intensification 2, 1, 3
If the patient were critically ill, different targets would apply (140-180 mg/dL with IV insulin infusion for levels ≥150-180 mg/dL) 2.
Practical Implementation Algorithm
Step 1: Measure HbA1c at admission to assess baseline glycemic control 4
Step 2: Initiate correctional insulin coverage:
- Use rapid-acting insulin (lispro, aspart, or glulisine) or regular insulin
- Typical starting scale: 2-4 units for glucose 180-220 mg/dL, adjusting based on insulin sensitivity 3
Step 3: Monitor for persistent hyperglycemia:
- Check glucose before meals and bedtime
- If ≥2 readings ≥180 mg/dL in 24 hours → add scheduled insulin 1
Step 4: When adding scheduled insulin:
- Basal-bolus regimen preferred for patients eating regular meals 3, 4
- Basal insulin alone for patients with poor or no oral intake 4
- Avoid sliding scale insulin as sole therapy for known diabetics 4, 5
Important Caveats and Pitfalls
Avoid hypoglycemia: This is the primary safety concern. The lower limit of 100 mg/dL provides a safety buffer, though some guidelines accept 72 mg/dL as the lower acceptable range 2. Never target euglycemia (80-110 mg/dL) in hospitalized patients due to increased mortality risk 2.
Higher targets may be acceptable (up to 200 mg/dL) in terminally ill patients, those with severe comorbidities, or settings without frequent monitoring capability 2.
Nutritional status matters: Adjust insulin regimens based on whether the patient is NPO, on tube feeds, or eating regular meals 1, 3.
Corticosteroid-induced hyperglycemia: May require NPH insulin or increased scheduled insulin doses 3.
Transition planning: Begin planning discharge regimen early, considering outpatient medication costs and patient preferences 1.
The evidence strongly supports treating this glucose level of 191 mg/dL, as values >180 mg/dL are consistently associated with increased morbidity, mortality, and length of stay 6, 4, 5. The most recent Endocrine Society guidelines (2022) provide the clearest algorithmic approach for this exact clinical scenario 1.